DOLE has been a surprising underperformer since last year's IPO. For patient investors, the sell-off looks like an opportunity
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.